Skip to content

Bull Bear Daily

Home
Business
Domestic
Economy
Money
Politics
Top News
Newsletters

Search for:

Home
2023
December
26
Bristol Myers to buy RayzeBio for $4.1 billion in targeted cancer therapy push
A sign stands outside a Bristol Myers Squibb facility in

A sign stands outside a Bristol Myers Squibb facility in

FILE PHOTO: A sign stands outside a Bristol Myers Squibb facility in Cambridge, Massachusetts, U.S., May 20, 2021. REUTERS/Brian Snyder/File Photo

Post navigation

Previous: Bristol Myers to buy RayzeBio for $4.1 billion in targeted cancer therapy push

Live Market Pulse

The charting technology is provided by TradingView. Learn how to use theTradingView Stock Screener.

Sign up for our free Bull Bear Daily Newsletter!

Discover new market trends and ideas directly to your inbox.

Search

Recent Posts

Agilent to acquire Biocare Medical in $950 million all-cash deal
Wall St ends higher as hopes of Iran war resolution offset inflation fears
Factbox-ECB policymakers play down need for swift action to combat surging energy costs
Germany’s industry makes unexpectedly weak start to 2026
Lego bets on Pokemon, interactive bricks as war threatens higher costs

You may have missed

2026-03-09T103000Z_4_LYNXMPEM280E2_RTROPTP_4_GERMANY-ODDLY.JPG

Newsletters

Agilent to acquire Biocare Medical in $950 million all-cash deal

Bull Bear Daily March 11, 2026

Newsletters

Wall St ends higher as hopes of Iran war resolution offset inflation fears

Bull Bear Daily March 11, 2026

Newsletters

Factbox-ECB policymakers play down need for swift action to combat surging energy costs

Bull Bear Daily March 11, 2026

2026-03-09T082757Z_1_LYNXMPEM280GY_RTROPTP_4_GERMANY-ECONOMY-INDUSTRIALORDERS.JPG

Newsletters

Germany’s industry makes unexpectedly weak start to 2026

Bull Bear Daily March 10, 2026

Home
Privacy Policy
Terms of Service
Disclaimer
Contact Us

Home
Privacy Policy
Terms of Service
Disclaimer
Contact Us

Copyright 2026 © All rights reserved | Bull Bear Daily | bullbeardaily.com

SITE_OK